https://www.epclusa.com/
EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option | Patient Site
Discover EPCLUSA® (sofosbuvir/velpatasvir), a prescription medicine used to treat chronic Hep C. See Important Safety Information including Important Warning.
hep c treatmentsofosbuviroptionpatientsite
https://hepatitiscnewdrugs.blogspot.com/2013/11/aasld-gileads-hepatitis-c.html
AASLD- Gilead's hepatitis C Sofosbuvir/ledipasvir plus ribavirin or GS-9669
hepatitis c
https://adisinsight.springer.com/drugsafety/803519863?error=cookies_not_supported&code=e1beb4cd-03ff-49e8-bbca-811cd0a017bb
Daclatasvir/sofosbuvir - AdisInsight
A Quasi experimental study conducted from January 2019 to June 2019 which included 255 patients described a 39-year-old man*, who experienced lack of efficacy
daclatasvirsofosbuviradisinsight
https://adisinsight.springer.com/drugsafety/803870032?error=cookies_not_supported&code=2285cb20-6b2a-48d9-8609-897c4d7392cd
Sofosbuvir - AdisInsight
In a retrospective study of 22 patients diagnosed with hepatitis C virus (HCV) infection conducted from December 2014 to June 2018, a patient [age and sex not
sofosbuviradisinsight
https://adisinsight.springer.com/patents/800043237
Sofosbuvir/velpatasvir/voxilaprevir - Gilead Sciences - AdisInsight
gilead sciencessofosbuviradisinsight
https://adisinsight.springer.com/drugsafety/803280213?error=cookies_not_supported&code=dfb73983-0328-4e81-9f04-ab6a02513203
Simeprevir/sofosbuvir - AdisInsight
In a multicentre observational study of 583 patients, two adult patients [ages not clearly stated and sexes not stated] were described, who developed
sofosbuviradisinsight
https://blogs.nejm.org/hiv-id-observations/index.php/velpatasvirsofosbuvir-makes-hcv-treatment-simpler-especially-for-genotypes-2-and-3/2016/07/03/
Velpatasvir/Sofosbuvir Makes HCV Treatment Simpler, Especially For Genotypes 2 and 3 - HIV and ID...
Jul 3, 2016 - One of the ways ID and hepatology hepatitis C experts like to show off is by discoursing on the nuances of cleverly named clinical trials, and how these impact...
https://file.scirp.org/Html/2-1900373_73392.htm
Study of the Efficacy of Triple Therapy of Sofosbuvir, Pegylated INFalpha 2a and Ribavirin in...
Purpose: The aim is evaluation of the efficacy of triple therapy of sofosbuvir, pegylated INFalpha 2a and ribavirin in treatment of chronic hepatitis C (CHC)...
https://my.clevelandclinic.org/health/drugs/18043-ledipasvir-sofosbuvir-tablets
Ledipasvir Sofosbuvir Tablets: Uses & Side Effects
Ledipasvir and sofosbuvir combine to treat hepatitis C. This virus causes chronic liver inflammation and long-term damage.
sofosbuvir tabletsusessideeffects
https://blogs.nejm.org/hiv-id-observations/index.php/simeprevir-sofosbuvir-and-the-limitations-of-the-cosmos/2014/07/31/
Simeprevir, Sofosbuvir, and the Limitations of the COSMOS - HIV and ID Observations HIV and ID...
Jun 4, 2015 - These are exciting times for hepatitis C treatment, as the approval of simeprevir and sofosbuvir in late 2013 have made curing this disease a whole lot easier....
and thesofosbuvirlimitationscosmoshiv
https://hepatitiscnewdrugs.blogspot.com/2013/11/simeprevir-and-sofosbuvir-next-wave-of.html
Simeprevir and Sofosbuvir-The Next Wave of Hepatitis C Treatment
the next wavehepatitis csofosbuvirtreatment
https://medlineplus.gov/druginfo/meds/a616034.html
Sofosbuvir and Velpatasvir: MedlinePlus Drug Information
Sofosbuvir and Velpatasvir: learn about side effects, dosage, special precautions, and more on MedlinePlus
sofosbuvirmedlineplusdruginformation
https://boris-portal.unibe.ch/entities/publication/c104ec8c-8925-413a-b675-3830aba6b494
Sofosbuvir/Velpatasvir for 12 Weeks in Genotype 1-4 HCV-Infected Liver Transplant Recipients
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0233446
Effectiveness of sofosbuvir based direct-acting antiviral regimens for chronic hepatitis C virus...
Background Hepatitis C virus (HCV) genotype 6 is the commonest cause of chronic hepatitis C infection in much of southeast Asia, but data on the effectiveness...
https://adisinsight.springer.com/drugsafety/803348402?error=cookies_not_supported&code=ca9ab2b9-8083-4d79-9f13-8f5cdc336d6f
Ledipasvir/sofosbuvir/sofosbuvir - AdisInsight
In a comprehensive analysis consisting of 12012 patients, 11 patients were described, who developed sofosbuvir or sofosbuvir/ledipasvir resistance leading to
sofosbuviradisinsight